Skinvisible, Inc. (SKVI) Licensee Receives First European Approval for Hand Sanitizer
4/27/2011 9:10:12 AM
LAS VEGAS, April 27, 2011 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCQB:SKVI) is pleased to announce that its licensee RHEI Pharmaceuticals NV has received marketing authorization from the Federal Agency for Medicines and Health Products in Belgium for HandSafe™, a unique chlorhexidine hand sanitizer made without alcohol. HandSafe™, referred to as DermSafe® in the US and Canada, is a unique, patent pending hand sanitizer formulated with 4% chlorhexidine gluconate and Skinvisible's patented polymer delivery system Invisicare®. HandSafe™ is made without alcohol so it will not dry the skin. It is proven to kill both bacteria and viruses for up to four hours including the viruses H1N1, H5N1 and H3N2.